⌘K

Home/Filings/4/0001209191-16-125842

4//SEC Filing

Kite Pharma, Inc. 4

Accession 0001209191-16-125842

CIK 0001510580operating

View on SEC.gov Company Profile

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 7:14 PM ET

Size

7.3 KB

Accession

0001209191-16-125842

Insider Transaction Report

Form 4

Period: 2016-06-01

Kite Pharma, Inc.KITE

Director

Transactions

Award
Common Stock
2016-06-01+1,950→ 141,017 total
Award
Director Stock Option (Right to Buy)
2016-06-01+7,000→ 7,000 total
Exercise: $50.87Exp: 2026-05-31→ Common Stock (7,000 underlying)

Holdings

Common Stock
(indirect: By Spouse)
31,865

Footnotes (1)

[F1]The stock option shall vest in 24 successive equal monthly installments following the date of grant.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Kite Pharma, Inc.

CIK 0001510580

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001510580

Filing Metadata

Form type: 4
Filed: Jun 2, 8:00 PM ET
Accepted: Jun 3, 7:14 PM ET
Size: 7.3 KB

View on SEC.gov